| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 650586 | 64618 | FLUCONAZOL NORMON 150 mg CAPSULAS DURAS EFG | FLUCONAZOL NORMON 150 mg CAPSULAS DURAS EFG , 4 cápsulas | 150 mg | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64618/64618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64618/64618_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-03-06 | 1 | 1 | 1 | 2002-03-06 | 2005-01-17 | 1 | 2011-10-20 | 840900 | View Edit Delete | |||||||||||
| 650587 | 64619 | FLUCONAZOL NORMON 200 mg CAPSULAS DURAS EFG | FLUCONAZOL NORMON 200 mg CAPSULAS DURAS EFG , 7 cápsulas | 200 mg | 5 | 7 | 43 | 7 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64619/64619_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64619/64619_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-03-06 | 1 | 1 | 1 | 2002-03-06 | 2005-01-17 | 1 | 2011-10-20 | 840918 | View Edit Delete | |||||||||||
| 650588 | 04295001 | XAGRID 0,5 MG CAPSULAS DURAS | XAGRID 0,5 MG CAPSULAS DURAS, 100 cápsulas | 0,5 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04295001/04295001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04295001/04295001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2005-01-19 | 1 | 1 | 1 | 2005-01-19 | 2005-01-19 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 650589 | 71754 | OLANZAPINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71754/71754_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71754/71754_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2011-08-10 | 1 | 2011-11-23 | 665572 | View Edit Delete | |||||||||||
| 650591 | 02206011 | ARIXTRA 5 MG/0,4 ML SOLUCION INYECTABLE, JERINGA PRECARGADA | ARIXTRA 5 MG/0,4 ML SOLUCION INYECTABLE, JERINGA PRECARGADA, 10 jeringas precargadas de 0,4 ml | 5 mg | 33 | 10 | 61 | 10 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02206011/02206011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02206011/02206011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2005-01-20 | 1 | 1 | 1 | 2005-01-20 | 2005-01-20 | 1 | 2011-02-21 | View Edit Delete | ||||||||||||
| 650592 | 02206014 | ARIXTRA 7,5 MG/0,6 ML SOLUCION INYECTABLE, JERINGA PRECARGADA | ARIXTRA 7,5 MG/0,6 ML SOLUCION INYECTABLE, JERINGA PRECARGADA, 10 jeringas precargadas de 0,6 ml | 7,5 mg | 33 | 10 | 61 | 10 jeringas precargadas de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02206014/02206014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02206014/02206014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2005-01-20 | 1 | 1 | 1 | 2005-01-20 | 2005-01-20 | 1 | 2021-12-23 | View Edit Delete | ||||||||||||
| 650597 | 71754 | OLANZAPINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA SANDOZ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71754/71754_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71754/71754_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2011-08-10 | 1 | 2011-11-23 | 665571 | View Edit Delete | |||||||||||
| 650600 | 72942 | VALSARTAN SANDOZ 160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN SANDOZ 160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72942/72942_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72942/72942_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-10-28 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 0 | 2011-10-10 | 672757 | View Edit Delete | |||||||||||
| 650602 | 04300001 | AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04300001/04300001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04300001/04300001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2005-02-08 | 1 | 1 | 1 | 2005-02-08 | 2005-02-08 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 650603 | 04300002 | AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 25 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04300002/04300002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04300002/04300002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2005-02-08 | 1 | 1 | 1 | 2005-02-08 | 2005-02-08 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 650605 | 66540 | MAGNESIA CINFA 2,4 g SUSPENSION ORAL | MAGNESIA CINFA 2,4 g SUSPENSION ORAL , 14 sobres | 2.400 mg | 35 | 14 | 64 | 14 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66540/66540_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66540/66540_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2005-01-21 | 1 | 1 | 1 | 2005-01-21 | 2005-01-21 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 650607 | 72644 | VALSARTAN/HIDROCLOROTIAZIDA SANDOZ 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA SANDOZ 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72644/72644_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72644/72644_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-10-28 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 1 | 2011-10-10 | 671773 | View Edit Delete | |||||||||||
| 650615 | 72645 | VALSARTAN/HIDROCLOROTIAZIDA SANDOZ 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA SANDOZ 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72645/72645_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72645/72645_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-10-28 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 0 | 2011-10-10 | 671828 | View Edit Delete | |||||||||||
| 650620 | 64280 | SIMVASTATINA ALMUS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SIMVASTATINA ALMUS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64280/64280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64280/64280_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A. | 2001-10-02 | 1 | 1 | 1 | 2001-10-02 | 2005-01-26 | 1 | 2011-02-25 | 990226 | View Edit Delete | |||||||||||
| 650622 | 59791 | AFLUON 1 mg/ml SOLUCIÓN PARA PULVERIZACIÓN NASAL | AFLUON 1 mg/ml SOLUCIÓN PARA PULVERIZACIÓN NASAL, 1 frasco de 20 ml | 1 mg/ml | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59791/59791_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59791/59791_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67965 | VEMEDIA PHARMA HISPANIA S.A. | 1993-02-01 | 1 | 1 | 1 | 1993-02-01 | 1995-03-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 650623 | 72220 | REPAGLINIDA SANDOZ 2 mg COMPRIMIDOS EFG | REPAGLINIDA SANDOZ 2 mg COMPRIMIDOS EFG, 90 comprimidos | 2 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72220/72220_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72220/72220_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-05-27 | 1 | 1 | 1 | 2010-05-27 | 2011-08-10 | 1 | 2024-06-14 | 669848 | View Edit Delete | |||||||||||
| 650629 | 66547 | DUODOPA 20 mg/ml + 5 mg/ml GEL INTESTINAL | DUODOPA 20 mg/ml + 5 mg/ml GEL INTESTINAL , 7 cartuchos de 100 ml | 20 mg/ml + 5 mg/ml | 12 | 7 | 57 | 7 cartuchos de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66547/66547_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66547/66547_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2005-02-03 | 1 | 1 | 1 | 2005-02-03 | 2005-02-03 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 650632 | 66548 | BISOLVON MUCOLITICO 1,6 mg/ ml JARABE | BISOLVON MUCOLITICO 1,6 mg/ ml JARABE, 1 frasco de 200 ml | 1,6 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66548/66548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66548/66548_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41334 | OPELLA HEALTHCARE SPAIN S.L. | 2005-01-26 | 1 | 1 | 1 | 2005-01-26 | 2005-01-26 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 650641 | 66568 | FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 600 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66568/66568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66568/66568_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2005-01-28 | 1 | 1 | 1 | 2005-01-28 | 2005-01-28 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 650649 | 71192 | LERCANIDIPINO SANDOZ 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LERCANIDIPINO SANDOZ 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71192/71192_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71192/71192_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2010-01-14 | 1 | 1 | 1 | 2010-01-14 | 2011-08-18 | 1 | 2011-11-23 | 664507, 663404 | View Edit Delete |
Page 62 of 1036, showing 20 records out of 20708 total, starting on record 1221, ending on 1240